Andy Chen

Medication non-adherence in inflammatory bowel diseases is associated with disability

Jonathan Perry, Andy Chen, Viraj C. Kariyawasam et al. · Intestinal Research · 2018 · 58 citations · Full text

The AETHERA Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma

Craig H. Moskowitz, Auayporn Nadamanee, Tamás Masszi et al. · Biology of Blood and Marrow Transplantation · 2015 · 18 citations · Full text

Aethera Trial, Relapsed/refractory Hodgkin Lymphoma, Immunology +21

Diffuse large B-cell lymphoma in adults aged 75 years and older: a single institution analysis of cause-specific survival and prognostic factors

Stephen D. Smith, Andy Chen, Stephen E. Spurgeon et al. · Therapeutic Advances in Hematology · 2013 · 17 citations · Full text

Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) for Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results of a Phase Ib/II Study

Hervé Tilly, Franck Morschhauser, Nancy L. Bartlett et al. · Blood · 2016 · 11 citations